Geron Corporation (GERN)
$3.92 -$0.14 (-3.52%) 4:38 PM 12/12/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$2.38B -
Day's Range
$3.83 - $4.01 -
Volume
5,599,973 -
52 Week Low / High
$1.64 - $5.34 -
PE Ratio
- -
PEG Ratio
-2.38 -
Dividend Frequency
-
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 5
- Strong Buy
- 5
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong Sell
- $4.83
- Target Price
Company News
-
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — Oct 17th, 2024
FOSTER CITY, Calif., October 17, 2024--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted non-statutory stock options to purchase an aggregate of 680,220 shares of Geron common stock as inducements to newly hi...
-
Geron to Announce Third Quarter 2024 Financial Results on November 7, 2024 — Oct 15th, 2024
FOSTER CITY, Calif., October 15, 2024--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company, today announced that it will release its third quarter 2024 financial results and business highlights before the market opens on Thursday, November 7, 202...
-
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — Oct 17th, 2024
FOSTER CITY, Calif., October 17, 2024--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted non-statutory stock options to purchase an aggregate of 680,220 shares of Geron common stock as inducements to newly hi...
-
Geron to Announce Third Quarter 2024 Financial Results on November 7, 2024 — Oct 15th, 2024
FOSTER CITY, Calif., October 15, 2024--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company, today announced that it will release its third quarter 2024 financial results and business highlights before the market opens on Thursday, November 7, 202...
-
Is Geron Corporation (GERN) the Best Stock Under $10 With High Potential? — Oct 10th, 2024
We recently compiled a list of 10 Stocks Under $10 With High Potential. In this article, we will look at where Geron Corporation (NASDAQ:GERN) ranks among the best stocks under $10 with high potential. How Does the Market Look Like in the Current Geopolitical Environment There has been o...
-
Geron to Announce Third Quarter 2024 Financial Results on November 7, 2024 — Oct 15th, 2024
FOSTER CITY, Calif., October 15, 2024--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company, today announced that it will release its third quarter 2024 financial results and business highlights before the market opens on Thursday, November 7, 202...
-
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — Oct 17th, 2024
FOSTER CITY, Calif., October 17, 2024--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted non-statutory stock options to purchase an aggregate of 680,220 shares of Geron common stock as inducements to newly hi...
-
Is Geron Corporation (GERN) the Hottest Penny Stock to Invest in According to Hedge Funds? — Oct 16th, 2024
In this article, we will look at the 8 Hot Penny Stocks To Invest In According to Hedge Funds. Let’s look at where Geron Corporation (GERN) stands against other hot penny stocks. Financial markets are betting that the Federal Reserve’s half-point interest rate cut in September will b...
-
Geron to Announce Third Quarter 2024 Financial Results on November 7, 2024 — Oct 15th, 2024
FOSTER CITY, Calif., October 15, 2024--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company, today announced that it will release its third quarter 2024 financial results and business highlights before the market opens on Thursday, November 7, 202...
-
Is Geron Corporation (GERN) the Best Stock Under $10 With High Potential? — Oct 10th, 2024
We recently compiled a list of 10 Stocks Under $10 With High Potential. In this article, we will look at where Geron Corporation (NASDAQ:GERN) ranks among the best stocks under $10 with high potential. How Does the Market Look Like in the Current Geopolitical Environment There has been o...
-
Is Geron Corporation (GERN) the Best Growth Stock Under $10 to Buy? — Oct 12th, 2024
We recently compiled a list of 13 Best Growth Stocks Under $10 to Buy. In this article we will look at where Geron Corporation (NASDAQ:GERN) ranks among the best growth stocks under $10 to buy. After a summer dip, stocks recovered in Q3 2024, setting new records after the quarter. More th...
-
Geron to Announce Third Quarter 2024 Financial Results on November 7, 2024 — Oct 15th, 2024
FOSTER CITY, Calif., October 15, 2024--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company, today announced that it will release its third quarter 2024 financial results and business highlights before the market opens on Thursday, November 7, 202...
-
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — Oct 17th, 2024
FOSTER CITY, Calif., October 17, 2024--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted non-statutory stock options to purchase an aggregate of 680,220 shares of Geron common stock as inducements to newly hi...
-
Geron to Announce Third Quarter 2024 Financial Results on November 7, 2024 — Oct 15th, 2024
FOSTER CITY, Calif., October 15, 2024--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company, today announced that it will release its third quarter 2024 financial results and business highlights before the market opens on Thursday, November 7, 202...
-
Geron Corp (GERN) Q2 2024 Earnings Call Highlights: Strong Financial Position Amid Early Rytelo ... — Oct 9th, 2024
Cash, Cash Equivalents, and Marketable Securities: Approximately $430 million as of June 30, 2024. Total Product Revenue (Net): Approximately $780,000 for the three and six months ended June 30, 2024. Total Revenues: $882,000 for the three months and $1.2 million for the six months ending ...
-
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — Oct 17th, 2024
FOSTER CITY, Calif., October 17, 2024--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted non-statutory stock options to purchase an aggregate of 680,220 shares of Geron common stock as inducements to newly hi...
-
Geron Corp (GERN) Q2 2024 Earnings Call Highlights: Strong Financial Position Amid Early Rytelo ... — Oct 9th, 2024
Cash, Cash Equivalents, and Marketable Securities: Approximately $430 million as of June 30, 2024. Total Product Revenue (Net): Approximately $780,000 for the three and six months ended June 30, 2024. Total Revenues: $882,000 for the three months and $1.2 million for the six months ending ...
-
Is Geron Corporation (GERN) the Best Growth Stock Under $10 to Buy? — Oct 12th, 2024
We recently compiled a list of 13 Best Growth Stocks Under $10 to Buy. In this article we will look at where Geron Corporation (NASDAQ:GERN) ranks among the best growth stocks under $10 to buy. After a summer dip, stocks recovered in Q3 2024, setting new records after the quarter. More th...
-
Is Geron Corporation (GERN) the Hottest Penny Stock to Invest in According to Hedge Funds? — Oct 16th, 2024
In this article, we will look at the 8 Hot Penny Stocks To Invest In According to Hedge Funds. Let’s look at where Geron Corporation (GERN) stands against other hot penny stocks. Financial markets are betting that the Federal Reserve’s half-point interest rate cut in September will b...
-
Is Geron Corporation (GERN) the Best Stock Under $10 With High Potential? — Oct 10th, 2024
We recently compiled a list of 10 Stocks Under $10 With High Potential. In this article, we will look at where Geron Corporation (NASDAQ:GERN) ranks among the best stocks under $10 with high potential. How Does the Market Look Like in the Current Geopolitical Environment There has been o...
-
Geron Corp (GERN) Q2 2024 Earnings Call Highlights: Strong Financial Position Amid Early Rytelo ... — Oct 9th, 2024
Cash, Cash Equivalents, and Marketable Securities: Approximately $430 million as of June 30, 2024. Total Product Revenue (Net): Approximately $780,000 for the three and six months ended June 30, 2024. Total Revenues: $882,000 for the three months and $1.2 million for the six months ending ...
-
Is Geron Corporation (GERN) the Hottest Penny Stock to Invest in According to Hedge Funds? — Oct 16th, 2024
In this article, we will look at the 8 Hot Penny Stocks To Invest In According to Hedge Funds. Let’s look at where Geron Corporation (GERN) stands against other hot penny stocks. Financial markets are betting that the Federal Reserve’s half-point interest rate cut in September will b...
-
Is Geron Corporation (GERN) the Best Stock Under $10 With High Potential? — Oct 10th, 2024
We recently compiled a list of 10 Stocks Under $10 With High Potential. In this article, we will look at where Geron Corporation (NASDAQ:GERN) ranks among the best stocks under $10 with high potential. How Does the Market Look Like in the Current Geopolitical Environment There has been o...
-
Is Geron Corporation (GERN) the Best Stock Under $10 With High Potential? — Oct 10th, 2024
We recently compiled a list of 10 Stocks Under $10 With High Potential. In this article, we will look at where Geron Corporation (NASDAQ:GERN) ranks among the best stocks under $10 with high potential. How Does the Market Look Like in the Current Geopolitical Environment There has been o...
-
Wall Street Analysts Rate Geron Corporation (GERN) as a Buy Amid Strong Growth Prospects — Oct 9th, 2024
We recently published a list of 10 Best Biotech Stocks To Buy Under $20. In this article, we are going to take a look at where Geron Corporation (NASDAQ:GERN) stands against the other best biotech stocks to buy under $20. The biotechnology industry is experiencing rapid growth, driven by ...
-
Wall Street Analysts Rate Geron Corporation (GERN) as a Buy Amid Strong Growth Prospects — Oct 9th, 2024
We recently published a list of 10 Best Biotech Stocks To Buy Under $20. In this article, we are going to take a look at where Geron Corporation (NASDAQ:GERN) stands against the other best biotech stocks to buy under $20. The biotechnology industry is experiencing rapid growth, driven by ...
-
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — Oct 17th, 2024
FOSTER CITY, Calif., October 17, 2024--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted non-statutory stock options to purchase an aggregate of 680,220 shares of Geron common stock as inducements to newly hi...
-
Is Geron Corporation (GERN) the Best Stock Under $10 With High Potential? — Oct 10th, 2024
We recently compiled a list of 10 Stocks Under $10 With High Potential. In this article, we will look at where Geron Corporation (NASDAQ:GERN) ranks among the best stocks under $10 with high potential. How Does the Market Look Like in the Current Geopolitical Environment There has been o...
-
Is Geron Corporation (GERN) the Best Growth Stock Under $10 to Buy? — Oct 12th, 2024
We recently compiled a list of 13 Best Growth Stocks Under $10 to Buy. In this article we will look at where Geron Corporation (NASDAQ:GERN) ranks among the best growth stocks under $10 to buy. After a summer dip, stocks recovered in Q3 2024, setting new records after the quarter. More th...
-
Is Geron Corporation (GERN) the Best Growth Stock Under $10 to Buy? — Oct 12th, 2024
We recently compiled a list of 13 Best Growth Stocks Under $10 to Buy. In this article we will look at where Geron Corporation (NASDAQ:GERN) ranks among the best growth stocks under $10 to buy. After a summer dip, stocks recovered in Q3 2024, setting new records after the quarter. More th...
-
Is Geron Corporation (GERN) the Best Growth Stock Under $10 to Buy? — Oct 12th, 2024
We recently compiled a list of 13 Best Growth Stocks Under $10 to Buy. In this article we will look at where Geron Corporation (NASDAQ:GERN) ranks among the best growth stocks under $10 to buy. After a summer dip, stocks recovered in Q3 2024, setting new records after the quarter. More th...
-
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — Oct 17th, 2024
FOSTER CITY, Calif., October 17, 2024--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted non-statutory stock options to purchase an aggregate of 680,220 shares of Geron common stock as inducements to newly hi...
-
Is Geron Corporation (GERN) the Best Stock Under $10 With High Potential? — Oct 10th, 2024
We recently compiled a list of 10 Stocks Under $10 With High Potential. In this article, we will look at where Geron Corporation (NASDAQ:GERN) ranks among the best stocks under $10 with high potential. How Does the Market Look Like in the Current Geopolitical Environment There has been o...
-
Is Geron Corporation (GERN) the Best Growth Stock Under $10 to Buy? — Oct 12th, 2024
We recently compiled a list of 13 Best Growth Stocks Under $10 to Buy. In this article we will look at where Geron Corporation (NASDAQ:GERN) ranks among the best growth stocks under $10 to buy. After a summer dip, stocks recovered in Q3 2024, setting new records after the quarter. More th...
-
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — Oct 17th, 2024
FOSTER CITY, Calif., October 17, 2024--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted non-statutory stock options to purchase an aggregate of 680,220 shares of Geron common stock as inducements to newly hi...
-
Wall Street Analysts Rate Geron Corporation (GERN) as a Buy Amid Strong Growth Prospects — Oct 9th, 2024
We recently published a list of 10 Best Biotech Stocks To Buy Under $20. In this article, we are going to take a look at where Geron Corporation (NASDAQ:GERN) stands against the other best biotech stocks to buy under $20. The biotechnology industry is experiencing rapid growth, driven by ...
-
Is Geron Corporation (GERN) the Best Growth Stock Under $10 to Buy? — Oct 12th, 2024
We recently compiled a list of 13 Best Growth Stocks Under $10 to Buy. In this article we will look at where Geron Corporation (NASDAQ:GERN) ranks among the best growth stocks under $10 to buy. After a summer dip, stocks recovered in Q3 2024, setting new records after the quarter. More th...
-
Is Geron Corporation (GERN) the Hottest Penny Stock to Invest in According to Hedge Funds? — Oct 16th, 2024
In this article, we will look at the 8 Hot Penny Stocks To Invest In According to Hedge Funds. Let’s look at where Geron Corporation (GERN) stands against other hot penny stocks. Financial markets are betting that the Federal Reserve’s half-point interest rate cut in September will b...
-
Is Geron Corporation (GERN) the Best Growth Stock Under $10 to Buy? — Oct 12th, 2024
We recently compiled a list of 13 Best Growth Stocks Under $10 to Buy. In this article we will look at where Geron Corporation (NASDAQ:GERN) ranks among the best growth stocks under $10 to buy. After a summer dip, stocks recovered in Q3 2024, setting new records after the quarter. More th...
-
Geron to Announce Third Quarter 2024 Financial Results on November 7, 2024 — Oct 15th, 2024
FOSTER CITY, Calif., October 15, 2024--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company, today announced that it will release its third quarter 2024 financial results and business highlights before the market opens on Thursday, November 7, 202...
-
Is Geron Corporation (GERN) the Hottest Penny Stock to Invest in According to Hedge Funds? — Oct 16th, 2024
In this article, we will look at the 8 Hot Penny Stocks To Invest In According to Hedge Funds. Let’s look at where Geron Corporation (GERN) stands against other hot penny stocks. Financial markets are betting that the Federal Reserve’s half-point interest rate cut in September will b...
-
Is Geron Corporation (GERN) the Hottest Penny Stock to Invest in According to Hedge Funds? — Oct 16th, 2024
In this article, we will look at the 8 Hot Penny Stocks To Invest In According to Hedge Funds. Let’s look at where Geron Corporation (GERN) stands against other hot penny stocks. Financial markets are betting that the Federal Reserve’s half-point interest rate cut in September will b...
-
Geron Corp (GERN) Q2 2024 Earnings Call Highlights: Strong Financial Position Amid Early Rytelo ... — Oct 9th, 2024
Cash, Cash Equivalents, and Marketable Securities: Approximately $430 million as of June 30, 2024. Total Product Revenue (Net): Approximately $780,000 for the three and six months ended June 30, 2024. Total Revenues: $882,000 for the three months and $1.2 million for the six months ending ...
-
Is Geron Corporation (GERN) the Hottest Penny Stock to Invest in According to Hedge Funds? — Oct 16th, 2024
In this article, we will look at the 8 Hot Penny Stocks To Invest In According to Hedge Funds. Let’s look at where Geron Corporation (GERN) stands against other hot penny stocks. Financial markets are betting that the Federal Reserve’s half-point interest rate cut in September will b...
-
Wall Street Analysts Rate Geron Corporation (GERN) as a Buy Amid Strong Growth Prospects — Oct 9th, 2024
We recently published a list of 10 Best Biotech Stocks To Buy Under $20. In this article, we are going to take a look at where Geron Corporation (NASDAQ:GERN) stands against the other best biotech stocks to buy under $20. The biotechnology industry is experiencing rapid growth, driven by ...
-
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — Oct 17th, 2024
FOSTER CITY, Calif., October 17, 2024--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted non-statutory stock options to purchase an aggregate of 680,220 shares of Geron common stock as inducements to newly hi...
-
Geron Corp (GERN) Q2 2024 Earnings Call Highlights: Strong Financial Position Amid Early Rytelo ... — Oct 9th, 2024
Cash, Cash Equivalents, and Marketable Securities: Approximately $430 million as of June 30, 2024. Total Product Revenue (Net): Approximately $780,000 for the three and six months ended June 30, 2024. Total Revenues: $882,000 for the three months and $1.2 million for the six months ending ...
-
Is Geron Corporation (GERN) the Hottest Penny Stock to Invest in According to Hedge Funds? — Oct 16th, 2024
In this article, we will look at the 8 Hot Penny Stocks To Invest In According to Hedge Funds. Let’s look at where Geron Corporation (GERN) stands against other hot penny stocks. Financial markets are betting that the Federal Reserve’s half-point interest rate cut in September will b...
-
Is Geron Corporation (GERN) the Best Stock Under $10 With High Potential? — Oct 10th, 2024
We recently compiled a list of 10 Stocks Under $10 With High Potential. In this article, we will look at where Geron Corporation (NASDAQ:GERN) ranks among the best stocks under $10 with high potential. How Does the Market Look Like in the Current Geopolitical Environment There has been o...
-
Geron to Announce Third Quarter 2024 Financial Results on November 7, 2024 — Oct 15th, 2024
FOSTER CITY, Calif., October 15, 2024--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company, today announced that it will release its third quarter 2024 financial results and business highlights before the market opens on Thursday, November 7, 202...
Portfolio
Comprised of 1 portfolios